These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2508264)

  • 21. [The activation of the immunosorptive properties of blood during its UV irradiation at therapeutic doses].
    Vasil'eva ZF; Shtil'bans VI; Samoĭlova KS; Obolenskaia KD
    Biull Eksp Biol Med; 1989 Dec; 108(12):689-91. PubMed ID: 2517485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusion medicine illustrated: blocked D phenomenon.
    Moiz B; Salman M; Kamran N; Shamsuddin N
    Transfusion; 2008 Aug; 48(8):1545-6. PubMed ID: 18713103
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 25. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemolytic disease of the newborn in monozygotic twins caused by anti-c alloantibodies of the rhesus system].
    Gligorović VN; Gligorović S
    Bilt Hematol Transfuz; 1980; 8(1):83-9. PubMed ID: 6802130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloimmunity to RhD in humans.
    Urbaniak SJ
    Transfus Clin Biol; 2006; 13(1-2):19-22. PubMed ID: 16574456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fetomaternal incompatibility due to Rhesus erythrocyte antigens other than antigen D].
    Faille N; Kremp O; Risbourg B; Olewniczak G; Maingourd Y; Dieval J; Delobel J
    Ann Pediatr (Paris); 1984 Oct; 31(8):657-60. PubMed ID: 6437316
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemolytic disease of the fetus.
    Spinnato JA
    Am J Obstet Gynecol; 1992 May; 166(5):1589-90. PubMed ID: 1595818
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hemolytic disease from rhesus anti-C antibodies in a surrogate pregnancy after oocyte donation. A case report.
    Mitchell S; James A
    J Reprod Med; 1999 Apr; 44(4):388-90. PubMed ID: 10319314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Term neonates with hemolytic disease of the newborn and necrotizing enterocolitis: a report of two cases.
    Roig JC; Burchfield DJ
    J Perinatol; 1994; 14(3):201-3. PubMed ID: 8064424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-D in Rh positive pregnancies.
    Prasad MR; Krugh D; Rossi KQ; O'Shaughnessy RW
    Am J Obstet Gynecol; 2006 Oct; 195(4):1158-62. PubMed ID: 17000249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S; al Omran A
    J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization.
    Oepkes D; van Kamp IL; Simon MJ; Mesman J; Overbeeke MA; Kanhai HH
    Am J Obstet Gynecol; 2001 Apr; 184(5):1015-20. PubMed ID: 11303214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J
    J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.